Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol OR hemp:

Phytochemistry of Cannabis sativa L. ElSohly MA et al. Prog Chem Org Nat Prod. (2017)

Is cannabis an effective treatment for joint pain? Miller RJ et al. Clin Exp Rheumatol. (2017)

Pharmacology of cannabinoids in the treatment of epilepsy. Gaston TE et al. Epilepsy Behav. (2017)

Search results

Items: 1 to 20 of 22145

1.

Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center.

von Wrede R, Moskau-Hartmann S, Amarell N, Elger CE, Helmstaedter C.

Epilepsy Behav. 2019 Aug 13;99:106458. doi: 10.1016/j.yebeh.2019.106458. [Epub ahead of print]

PMID:
31419634
2.

Lifestyle, appearance satisfaction and depressive symptoms in 13-16 years old Norwegian adolescents - A cross-sectional study.

Hestetun I, Svendsen MV, Oellingrath IM.

Nord J Psychiatry. 2019 Aug 16:1-8. doi: 10.1080/08039488.2019.1653964. [Epub ahead of print]

PMID:
31419392
3.

Incidence of Pediatric Cannabis Exposure Among Children and Teenagers Aged 0 to 19 Years Before and After Medical Marijuana Legalization in Massachusetts.

Whitehill JM, Harrington C, Lang CJ, Chary M, Bhutta WA, Burns MM.

JAMA Netw Open. 2019 Aug 2;2(8):e199456. doi: 10.1001/jamanetworkopen.2019.9456.

PMID:
31418807
4.

Exploratory analysis of genetic variants influencing molecular traits in cerebral cortex of suicide completers.

Rodríguez-López ML, Martínez-Magaña JJ, Cabrera-Mendoza B, Genis-Mendoza AD, García-Dolores F, López-Armenta M, Flores G, Vázquez-Roque RA, Nicolini H.

Am J Med Genet B Neuropsychiatr Genet. 2019 Aug 16. doi: 10.1002/ajmg.b.32752. [Epub ahead of print]

PMID:
31418530
5.

An examination of how age of onset for alcohol, cannabis, and tobacco are associated with physical activity, screen time and BMI as students are preparing to graduate from high school.

Williams GC, Battista K, Leatherdale ST.

Prev Med Rep. 2019 Jul 23;15:100956. doi: 10.1016/j.pmedr.2019.100956. eCollection 2019 Sep.

6.

A Rare Case of Cannabis-induced Acute Pancreatitis.

Ghazaleh S, Alqahtani A, Nehme C, Abugharbyeh A, Said Ahmed TS.

Cureus. 2019 Jun 11;11(6):e4878. doi: 10.7759/cureus.4878.

PMID:
31417823
7.

Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation.

Murkar A, Kent P, Cayer C, James J, Durst T, Merali Z.

Front Behav Neurosci. 2019 Aug 1;13:174. doi: 10.3389/fnbeh.2019.00174. eCollection 2019.

8.

Characterization and Phytotoxicity Assessment of Essential Oils from Plant Byproducts.

Smeriglio A, Trombetta D, Cornara L, Valussi M, De Feo V, Caputo L.

Molecules. 2019 Aug 14;24(16). pii: E2941. doi: 10.3390/molecules24162941.

9.

[Medical Cannabis-Related Relapse in a Patient with a History of Alcohol Abuse].

Flöther L, Peitek K, Bucher M, Benndorf RA.

Dtsch Med Wochenschr. 2019 Aug;144(16):1135-1137. doi: 10.1055/a-0805-1973. Epub 2019 Aug 15. German.

PMID:
31416105
10.

Cannabis-based medicinal products and the role of the doctor: should we be cautious or cautiously optimistic?

Braithwaite I, Newton-Howes G, Oldfield K, Semprini A.

N Z Med J. 2019 Aug 16;132(1500):82-88.

PMID:
31415502
11.
12.

Cannabis in New Zealand: a conundrum, and some good news.

Boden JM.

N Z Med J. 2019 Aug 16;132(1500):9-11. No abstract available.

PMID:
31415494
13.

Opportunities for cannabis in supportive care in cancer.

Kleckner AS, Kleckner IR, Kamen CS, Tejani MA, Janelsins MC, Morrow GR, Peppone LJ.

Ther Adv Med Oncol. 2019 Aug 1;11:1758835919866362. doi: 10.1177/1758835919866362. eCollection 2019. Review.

14.

Adherence to prescription guidelines for medical cannabis in disability claimants.

Elias DA, MacLaren VV, Hill-Elias R, Metcalfe AWS.

Can Fam Physician. 2019 Aug;65(8):e339-e343.

15.

Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial.

Sheridan Rains L, Marston L, Hinton M, Marwaha S, Craig T, Fowler D, King M, Omar RZ, McCrone P, Spencer J, Taylor J, Colman S, Harder C, Gilbert E, Randhawa A, Labuschagne K, Jones C, Stefanidou T, Christoforou M, Craig M, Strang J, Weaver T, Johnson S.

BMC Med. 2019 Aug 15;17(1):161. doi: 10.1186/s12916-019-1395-5.

16.

Cannabidiol (CBD) use in psychiatric disorders: A systematic.

Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F.

Neurotoxicology. 2019 Aug 11. pii: S0161-813X(19)30077-4. doi: 10.1016/j.neuro.2019.08.002. [Epub ahead of print] Review.

PMID:
31412258
17.

[Party drugs : when « recreation » rhymes with « consultation »].

Merlo S, Jamme S, Gartner B, Fehlmann C.

Rev Med Suisse. 2019 Aug 14;15(658):1394-1396. French.

PMID:
31411829
18.

Whole Plastome Sequences of Two Drug-Type Cannabis: Insights Into the Use of Plastid in Forensic Analyses.

Matielo CBD, Lemos RPM, Sarzi DS, Machado LO, Beise DC, Dobbler PCT, Castro RM, Fett MS, Roesch LFW, Camargo FAO, Stefenon VM.

J Forensic Sci. 2019 Aug 14. doi: 10.1111/1556-4029.14155. [Epub ahead of print]

PMID:
31411746
19.

Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics.

Pérez-Pérez M, Pérez-Rodríguez G, Fdez-Riverola F, Lourenço A.

J Med Internet Res. 2019 Aug 15;21(8):e12610. doi: 10.2196/12610.

20.

Commentary on Hamilton et al. (2019): Why aren't cannabis use rates declining among US adolescents?

Grucza RA, Borodovsky JT.

Addiction. 2019 Aug 13. doi: 10.1111/add.14758. [Epub ahead of print] No abstract available.

PMID:
31410928

Supplemental Content

Loading ...
Support Center